doi: 10.1155/2022/5632744 Summary Keywords anlotinib, malignant melanotic nerve sheath tumor, metastasis, radiotherapy, targeted therapy Citation Zhu H, Shen W, Yang H, Han X, Li W, Xie J, Tan Y, Lu P, Ji Y and Zhang Y (2026) Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor
The therapeutic benefits of GLP-1RA go beyond T2D and obesity treatment
Research applications requiring UV-independent tanning or appetite modulation must use Melanotan-2
This leads to an increase in muscle mass and strength over time
GIP was long considered a problematic hormone in obesity research because it appeared to promote fat storage
Amiri F, Dahaj MM, Siasi NH, Deyhim MR